Sensyne Health Share Discussion Threads

[edwardt] 07/1/2022 09:54

sanofi SA and Exscientia PLC are to partner on drug development in oncology and immunology in a deal that could see the latter receive up to $5.3 billion, the two pharmaceutical companies said Friday.

Paris-listed Sanofi and U.K.-based Exscientia will collaborate to identify and select target projects, using Exscientia's artificial-intelligence-driven personalized medicine platform.

Under the research, collaboration and licensing agreement, the two companies will develop up to 15 novel small-molecule candidates in oncology and immunology, they said in a joint release.

Sanofi will pay Exscientia an upfront cash payment of $100 million, while future payments could reach some $5.2 billion, relating to commercial, clinical and regulatory milestones, the companies said.

If Sanofi commercializes a therapeutic treatment from the collaboration, Exscientia will also be eligible to receive tiered royalties on product sales ranging from a rate of high single digits to mid-teens, and an option for clinical co-investment to increase the royalty rate up to 21% on net sales of cofunded products, the companies said.

[billy3] 24/12/2021 10:00

Two good RNS today with agreements for use of AI platform.
With the payments mentioned could be towards half million revenue.
Of course, cash burn is way way over that !

But it shows confidence in the product.
Tempting to buy back in here now but only one buy showing this morning and all the rest are sells with share price moved a penny at open.

Seems unloved at the moment so will wait a little longer and see.

It's a difficult call as a buyout could easily be a 50% markup from here which would still be below where I sold my holdings.

[billy3] 23/12/2021 09:21

I was reading about MBOs recently.
It said that the managers buying need to have a good knowledge of the business.
Knowing much more than shareholders.

Drayton fits that bill.
It also said that the price paid needs to be well in excess of the current price to make it worth the majority of shareholders selling.

Now is it a coincidence that Sens were doing just fine and had income projected to come on stream with contracts for the new AI system when the newspaper article appears with Drayson dropping a bombshell about the companies ability to carry on ?

There was always a risk of another share issues, but failure wasn’t discussed.

Then, the share price drops and drops.
Then we have Drayson suggesting a MBO ?

Well that’s very convenient as the share price has now halved and he holds loads of shares and can buy the rest a lot cheaper.

I’ve not doubt Gatemore will want an amazing deal or they will reject any offer.
They want a Nasdaq listing.

I’d love to be a fly on the wall right now.
It’s likely (if we believe the last update) they now have income from the contracts they mentioned as in the pipeline. But can’t say as must be in a closed period so embargoed.

I think this will end in an announcement for either Nasdaq go ahead or MBO.

Anyone think MBO will happen and why ?

[billy3] 21/12/2021 13:23

Good point Edward.

I reckon you’re right.

[edwardt] 21/12/2021 13:05

i guess given the current 'mbo' situation there will be a black out on newsflow re contract wins but could be wrong.

[billy3] 17/12/2021 11:44

Agreed. I managed to get out 126p or
Thereabouts selling in tranches.

Took a hit on those but up plenty overall after trading them for a couple of years.

Support looks else 60p but under the current circumstances I doubt that makes much difference.

I was initially looking to buy back under 100p but it is a slow
Slide at the moment so will wait and see wait materialises.

Still plenty of opportunity and long term all the work has been done.

It’s all been a bit quiet about all the ‘contracts in the pipeline’ ?

[zulu_principle] 17/12/2021 11:31

Still keeping an eye on these but have very low expectations. If positive news emerges we might miss some of the initial bounce but there's plenty of upside potential for those of us who decided to sell shortly after the last trading update.

[edwardt] 15/12/2021 09:58

blimey this is a drip drip at the minute.

[rambutan2] 09/12/2021 22:43

Meanwhile, back at base:

DECEMBER 1, 2021

Using de-identified and anonymised longitudinal patient data from Oxford University Hospitals NHS Foundation Trust, Sensyne Health’s data science team has developed a novel algorithm to discover sub-groups of patients who share both a similar medical history and future clinical endpoints.

[rambutan2] 09/12/2021 22:28

On the same theme, on mon it was announced that BenevolentAI is to go public via spac:

"Terms of the transaction imply a pre-money equity valuation of €1.1bn and a post-money equity valuation of €1.5bn..."

[edwardt] 09/12/2021 14:27

astonishing disconnect.

[rambutan2] 08/12/2021 21:57

Out of interest, and noting valuations of $2.8bn and $2.7bn respectively:

October 5, 2021 OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI), an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner, today announced the closing of its previously-announced upsized initial public offering in the United States of 15,927,500 American Depositary Shares (“ADSs”) representing 15,927,500 ordinary shares, including 2,077,500 ADSs sold pursuant to the full exercise of the underwriters’ previously granted option to purchase additional ADSs. All ADSs sold in the offering were offered by Exscientia at a public offering price of $22.00 per ADS. The total gross proceeds to Exscientia from the offering were approximately $350.4 million, prior to deducting underwriting discounts and commissions and estimated offering expenses payable by Exscientia. The offering was upsized from the number of shares offered at launch and priced at the top of the price range indicated at launch.




PALO ALTO, Calif. and LONDON, Oct. 21, 2021 /PRNewswire/ -- Babylon Holdings Limited ("Babylon"), one of the world's fastest-growing digital healthcare companies, today announced that it has completed its business combination with Alkuri Global Acquisition Corp. (NASDAQ: KURI, KURIU and KURIW) ("Alkuri"), a special purpose acquisition company. The transaction was approved on October 20, 2021 by Alkuri's shareholders. Babylon's Class A ordinary shares and its warrants will begin trading on the New York Stock Exchange ("NYSE") on October 22, 2021 under the new ticker symbols "BBLN" and "BBLN.W", respectively.

[edwardt] 06/12/2021 20:02

Better than buying them nearer £1.70!

[billy3] 17/11/2021 16:48

I saw that and was having palpitations. Even though I’m not holding at the moment.

I went to check RNS and get my cheque book out. No RNS.

Checked level 2 and was showing 97/99 so guessed it was an erroneous trade.

[czeck] 17/11/2021 16:20

my bad I reacted instantly and sold at a loss...oh well onwards and upwards. GLA

[jane deer] 17/11/2021 16:09

I think that print at 48.70p is just an error. I think the stock is still bid at 97p ish.

[czeck] 17/11/2021 15:51

What was happening here? Down almost 50%?

[rambutan2] 09/11/2021 02:58

Danish hedge fund appears to have bought 2.1m (1.27%) last week:

[davemarn] 07/11/2021 21:30

billy, careful its short sellers at work me thinks!

Meanwhile,

Angus Energy 0.90p
Positives
• Equipment should be arriving on site Nov 21 – Feb 22 proving this isn’t hot air!
• Permitting and Approvals expected early December 2021
• First time in 2 years a Project is about to become a reality early 2022
• Huge rise in Gas Prices (300-400%): 51% stake in onshore Saltfleeby Gas Asset
• 52% recent upgrade to NPV10 from a revised CPR of Gas Asset now £25.5m (£9m market cap)
• £12m fully funded for Saltfleeby
• Sidetrack to Gas Project Planning Permission in place to try and double output
• £1.4m Convertible Loan Note holdings extended deadline to April 2023 for final payment!
• 2x Director Buys of 1m each mid 2021
• £8m potential funding with Aleph and Associates for a valid Geothermal play
• 165m Warrants of £2.1m at 1.36p average potentially available
• 26m Employee Options at 1.5p but fully vesting at 2p too
Negatives
• A group of Locals persistently fester on UK Share Forums to stop any buying momentum, the success in market cap makes it harder to stop any of their projects dead in its tracks!
• A substantial undercurrent set of Short Sellers who seem to be betting against delivery and pre-gas price rally; now hurting and desperate to close out their positions – towards First Gas Q1-Q2 2022. Their short positions could create a dramatic squeeze to 2p alone IMO.
• Legacy Oil Assets and failed projects knocked share price and confidence of Long Term Holders
• Geothermal Progress Seems Slow
• Delays seem to bother some impatient traders but Aleph have stumped £12m loan!
Share Price Predictions?
• Harmonics showing 2-3.5p target?
• Management believes 3.5p per share is Fair Value vs. 0.90p share price
GLA WTFDIK DYOR

[rambutan2] 05/11/2021 16:08

Was some buying - abrdn added 823,134 at £1 yesterday, to take them to 3,701,100 2.25%.

[billy3] 04/11/2021 15:44

It's pretty much constant selling st the moment:-(